RT Journal Article
SR Electronic
T1 Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001391corr1
DO 10.1136/jitc-2020-001391corr1
VO 9
IS 11
YR 2021
UL http://jitc.bmj.com/content/9/11/e001391corr1.abstract